[11] Clinical studies such as the SUSTAIN programme (semaglutide) and AWARD trials (dulaglutide) demonstrate that GLP-1 receptor agonists can reduce HbA1c by approximately 0.81.5% on average, with some patients achieving greater reductions depending on baseline values and adherence
The SUPRPASS-4 trial (262), involving 2002 participants with high-risk cardiovascular profiles followed for up to 104 weeks, showed no difference in 4-MACE events (cardiovascular death, myocardial infarction, stroke, and hospitalization for unstable angina) with tirzepatide compared to insulin glargine (HR 0.74
Knowing that your medication is fully potent removes one variable from the equation, making it easier to identify whether side effects are dose-related, timing-related, or caused by other factors
medicines-contaminated sharps require a yellow-lidded sharps bin for safe disposal
Routine calcitonin testing or thyroid ultrasound is not established as an effective screening strategy for semaglutide users
What this does not mean This does not mean you can get MariTide as a treatment it's unapproved everywhere and only exists legitimately inside clinical trials
